SyntekaBio, Inc. (KOSDAQ:226330)
South Korea
· Delayed Price · Currency is KRW 7,520.00
-210.00 (-2.72%)
At close: Jun 27, 2025, 3:30 PM KST
SyntekaBio Revenue
SyntekaBio had revenue of 868.81M KRW in the quarter ending March 31, 2025, with 13,881.69% growth. This brings the company's revenue in the last twelve months to 983.48M, up 677.81% year-over-year. In the year 2024, SyntekaBio had annual revenue of 120.89M, down -2.04%.
Revenue (ttm)
983.48M
Revenue Growth
+677.81%
P/S Ratio
120.24
Revenue / Employee
n/a
Employees
n/a
Market Cap
118.25B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 120.89M | -2.52M | -2.04% |
| Dec 31, 2023 | 123.41M | -120.59M | -49.42% |
| Dec 31, 2022 | 243.99M | -72.67M | -22.95% |
| Dec 31, 2021 | 316.66M | -293.02M | -48.06% |
| Dec 31, 2020 | 609.68M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 308.10T |
| SK hynix | 71.40T |
| Samsung Biologics | 4,898.69B |
| LG Energy Solution | 25.76T |
| Hyundai Motor Company | 178.98T |
| NAVER | 11.00T |
| Doosan Enerbility | 15.88T |
| Hanwha Aerospace | 15.28T |